Terumo Corp. (OTCMKTS:TRUMY) Short Interest Update

Key Points

• Terumo Corp. experienced a significant increase in short interest, rising 73.1% from July to a total of 37,400 shares by August 15th.
• The company reported $0.20 earnings per share for the quarter, exceeding estimates, but revenue fell short with $1.76 billion compared to the predicted $1.80 billion.
• Terumo's stock rose 0.6% to $17.85 during trading, with a market cap of $26.43 billion and a price-to-earnings ratio of 31.32.

Terumo Corp. (OTCMKTS:TRUMY - Get Free Report) saw a significant growth in short interest in August. As of August 15th, there was short interest totaling 37,400 shares, agrowthof73.1% from the July 31st total of 21,600 shares. Based on an average daily volume of 178,400 shares, the short-interest ratio is currently 0.2 days. Based on an average daily volume of 178,400 shares, the short-interest ratio is currently 0.2 days.

Terumo Stock Up 0.6%

Shares of TRUMY traded up $0.10 during trading hours on Friday, reaching $17.85. 118,767 shares of the stock traded hands, compared to its average volume of 106,440. The company has a current ratio of 2.64, a quick ratio of 1.53 and a debt-to-equity ratio of 0.07. The stock has a fifty day simple moving average of $17.57 and a 200 day simple moving average of $18.20. Terumo has a 52 week low of $15.95 and a 52 week high of $21.22. The company has a market cap of $26.43 billion, a price-to-earnings ratio of 31.32 and a beta of 0.79.

Terumo (OTCMKTS:TRUMY - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.20 earnings per share for the quarter, beating analysts' consensus estimates of $0.17 by $0.03. Terumo had a net margin of 12.09% and a return on equity of 9.19%. The company had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.80 billion.

About Terumo

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.